Rebecca Derbes, Jonathan Hakun, Daniel Elbich, Lindsay Master, Sheri Berenbaum, Xuemei Huang, Orfeu M Buxton, Anne-Marie Chang, Cristina I Truica, Kathleen M Sturgeon
Endocrine therapy (ET) for breast cancer treatment is associated with cognitive complaints, but their etiology is poorly understood. To address this, we developed and implemented an ambulatory assessment protocol consisting of wearable activity monitors, brief surveys of affect, context, and perceived impairments, and ultra-brief performance-based measures of cognition. Newly diagnosed, ER/PR+, stage 0-III, female breast cancer patients, were recruited. Ambulatory assessments were conducted on smart phones and wearable activity monitors were used to monitor sleep and physical activity...
April 9, 2024: Scientific Reports